Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Titel:
Tumor lysate particle only vaccine (TLPO) vs. Tumor lysate particle-loaded, dendritic cell vaccine (TLPLDC) to prevent recurrence in resected stage III/IV melanoma patients: Results of a phase I/IIa trial
Auteur:
Van Decar, Spencer G. Carpenter, Elizabeth L. Adams, Alexandra M. Chick, Robert C. Clifton, Guy T. Stojadinovic, Alex Vreeland, Timothy J. Valdera, Franklin A. Tiwari, Ankur O'Shea, Anne E. McCarthy, Patrick M. Hale, Diane F. Bohan, Phillip M Kemp Hickerson, Annelies T. Cindass, Jessica L. Hyngstrom, John Berger, Adam C. Jakub, James W. Sussman, Jeffrey J. Shaheen, Montaser Yu, Xianzhong Wagner, Thomas Faries, Mark B. Peoples, George E.